Raymond James Keeps a Buy Rating on Premier (PINC)

Raymond James analyst John Ransom maintained a Buy rating on Premier (PINCResearch Report) today. The company’s shares closed last Tuesday at $35.06.

According to TipRanks.com, Ransom is a 5-star analyst with an average return of 15.6% and a 65.9% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Oak Street Health, and Acadia Healthcare.

Currently, the analyst consensus on Premier is a Moderate Buy with an average price target of $37.40.

See today’s analyst top recommended stocks >>

Based on Premier’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $423 million and net profit of $43.97 million. In comparison, last year the company earned revenue of $320 million and had a net profit of $36.49 million.

Based on the recent corporate insider activity of 26 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of PINC in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Premier, Inc. operates as a holding company with interests in health services. It specializes in data and analytics, supply chain solutions, advisory and other services. It operates through the Supply Chain Services and Performance Services segments. The Supply Chain Services segment offers products and services such as group purchasing, specialty pharmacy, direct sourcing, managed services, and Software-as-a-Service Informatics products. The Performance Services segment provides information technology analytics, and workflow automation and advisory services. The company was founded on May 14, 2013 and is headquartered in Charlotte, NC.